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Abstract  
Purpose. Describing the psychometric characteristics and diagnostic accuracy of the 
Accelerator 4-Alternative Forced-Choice Flicker Test prototype (A4FTp) for detecting chronic 
open angle glaucoma (COAG)  
Methods. A4FTp measures temporally modulated flicker thresholds in regions of the visual 
field with high susceptibility to glaucomatous loss. We initially evaluated its psychometric 
properties on 20 normals (aged 33.8 ± 8.5 years) who were tested multiple times over a period 
of 3m. All subjects underwent 4 repetitions for shorter (T8) and longer (T12) staircase 
termination criteria, to determine the most suitable threshold criterion. Four randomly selected 
subjects underwent a total of 10 repetitions to study test-retest repeatability and learning 
effects. To determine its diagnostic accuracy, one eye of 40 participants with COAG and 38 
normal controls were tested with the A4FTp in comparison with the Frequency Doubling 
Technology (FDT) (C20-5 programme) and iVue Spectral Domain Optical Coherence 
Tomography (SD-OCT). Tests were conducted in a random order with results masked to the 
clinician conducting the reference ophthalmic examination. The accuracy of each test was 
determined by analysis of the area under the receiver operator characteristics curve (AROC).  
Results. A4FTp flicker thresholds were stable, with standard deviations of only 0.52 decilog 
(dL) for T8, increasing to 1.32 dL for T12, and no significant flicker sensitivity threshold 
improvement over the 10 repeat runs. T8 was superior to T12 on several other measures, so 
it was used for the remaining comparisons. In terms of diagnostic accuracy, the mean AUROC 
for the three tests were; A4FTp (T8 criterion) (0.82, 95% confidence interval (0.73-0.92)), SD-
OCT (any RNFL parameter p<1% level) (0.90 (0.83-0.97)) and FDT (one or more locations 
missed at p<5% level) (0.91 (0.82-0.96)). There was no statistical difference in AUROC 
between A4FTp and SD-OCT (p=0.18) or FDT (p=0.12). The A4FTp test duration averaged 
just over 2 minutes per eye, taking approximately one third of the time for completion of the 
HFA SITA 24-2 algorithm (conducted as part of the reference examination) and twice the time 
for the suprathreshold FDT.  
Conclusion. Test accuracy for the A4FTp was comparable to those of the FDT and SD-OCT 
for the detection of COAG. Time taken to complete the A4FTp was relatively short and initial 
results are promising. With further refinement, the A4FTp could have a future role in glaucoma 
detection. 
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Introduction 
Visual field testing remains one of the most important tools for identifying and monitoring vision 
loss in glaucoma.(1) Since the introduction of automated perimetry in the early 1970s, almost 
all developments in perimetry have focused on either improving the sensitivity of the tests to 
early visual field damage or increasing test efficiency and speed.(2, 3) However, the lack of 
portability of current perimeters means that the assessment of visual function remains difficult 
outside the normal clinical setting. The advent of touch screen and tablet-technology has 
created new opportunities for the development of a portable low cost glaucoma-screening test 
that could be used in a home setting or in remote underserved communities. An iPad-based 
threshold perimeter based on the Humphrey 24-2 test grid has recently been developed which 
shows good diagnostic performance for the detection of glaucoma.(4, 5) 
The aim of this proof of concept study was to develop a simple, affordable and rapid glaucoma-
screening test that could potentially be used to detect functional vision loss outside the normal 
clinical setting. We also compared the performance of the new test with commercially available 
glaucoma screening technologies that detect structural or functional glaucomatous damage. 
The new test incorporates a new psychophysical algorithm that measures flicker sensitivity 
thresholds in areas of the visual field that are susceptible to glaucomatous visual field loss. 
Temporal modulation flicker uses a stimulus that is matched in luminance to the background, 
the contrast of the stimulus is then modulated temporally at a fixed spatial frequency, and the 
amplitude of the flicker modulation needed to detect the stimulus is determined.(6) Sensitivity 
to temporal modulation flicker has been shown to be effective in separating normal subjects 
from glaucoma patients, suggesting that the stimulus is the method of choice for detecting 
glaucomatous damage using flicker perimetry.(7-10) The other advantage of flicker perimeter 
methods is that they are relatively unaffected by optical blur due to media opacification or 
uncorrected refractive error, which is particularly important for assessing visual function in the 
field.(11)  
Another feature of the current test design is the use of extended stimulation areas at a small 
number of test locations. Previous studies have shown that the large numbers of stimulus 
locations used in current threshold perimeters are not always necessary to achieve high levels 
of sensitivity; good diagnostic performance can be achieved using relatively few test locations, 
confined to areas that are particularly prone to glaucomatous damage.(12-14) Moreover, one of 
the most common indices of glaucomatous loss is the Mean Deviation of the Humphrey Field 
Analyzer, which focuses on the average loss across large areas of the retina.(15) The 
philosophy of the stimulus design in the current test is therefore to use large stimuli that 
integrate information across extended retinal regions, with the further advantage of a potential 
reduction in test times. 
4 
 
We therefore determined that an appropriate paradigm for this purpose would be a four-
alternative forced-choice temporal protocol (4AFTp), which is becoming increasingly popular 
in psychophysical investigations. It has two great advantages over 2AFC. One is that the false 
alarm rate is only 25%, giving greater discriminative power from each choice. The other is that 
all four selected locations are tested in the same state of the participant, so any practice or 
fatigue effects are equated across the four locations, giving a more accurate comparison of 
their relative sensitivities. 
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Materials and methods 
This study was approved by the School of Health Sciences Research Ethics Committee, City, 
University of London and conducted per the tenets of Declaration of Helsinki. Written informed 
consent was obtained from all participants.  
 
1. Development of the Accelerator 4-Alternative Forced-Choice Flicker Test prototype 
(A4FTp) 
 
Stimulus Design 
There is evidence to suggest that high sensitivity in glaucoma detection can be achieved with 
relatively few perimetric stimuli.(16-19) Whilst the informational value of stimulus locations in 
susceptible areas of the visual field may be high, the correlation between adjacent test 
locations limits the value of adding multiple stimuli in these areas The choice of stimulus 
location for this first iteration of the A4FTp was based on the study by Wang and Henson(14) 
who used optimised sub-sets of the standard 24-2 test pattern, based on the PPV of each test 
location that broadly corresponded to the typical patterns of glaucomatous visual field loss that 
reflect the course of retinal nerve fibers.(20, 21) Two large circular stimuli (11° diameter) were 
located in the temporal superior and inferior arcuate regions 9-21° from fixation, with the other 
two stimuli (11.7° diameter) spanning the horizontal meridian (14-26° from fixation) at the 
endpoints of the nasal arcuate sweep of the nerve fibre layer, the visual field location subject 
to the well-known ‘nasal step’ (Figure 1).  
Stimuli were displayed at a viewing distance of 33 cm on a high refresh rate screen (120 Hz) 
in a uniform red field (610 nm), designed to minimise transmission losses in the optic 
media.(22)The target stimulus in each of four test fields was a burst of 30 Hz effectively 
sinusoidal flicker § with the same mean luminance as the background (19 cd/m2), which was 
ramped on and off according to a 1 s raised cosine envelope in order to avoid onset and offset 
transients.  
 
 
§  Since the harmonics of the 120 Hz sampled waveform at 60 Hz and above would be close 
to or beyond human temporal resolution, the waveform can be considered effectively 
sinusoidal 
6 
 
 
 
Figure 1. Spatial location of the A4FTp flicker regions for the right eye compared to the HFA 
24-2 pattern. The black triangle corresponds to the location of the blind spot. The configuration 
was mirror-reversed for testing the left eye. 
 
Algorithm development 
The screening algorithm uses a rapid four-alternative forced-choice staircase paradigm, with 
the results plotted in decilog (dL) units (or 1/10th of log10 base intervals, following the 
simplifying convention relative to dB units adopted by one of the authors.(6) Each one-up/two-
down staircase in log modulation steps of 1 dL terminates when the standard deviation of the 
last n trials becomes less than 1 step (where n was either 8 steps (T8) or 12 steps (T12) in 
different conditions). Unlike conventional staircases, this straightforward algorithm ensures 
that the staircase has reached a stable asymptotic performance level of low variability.  
The algorithm was implemented and tested on a Dell computer with specifications Inter core 
2 Duo CPU E7500 @2.93 GHz and 4 GB RAM, displayed on a 144 Hz Asus VG248QE 24-
inch 3D LED monitor running at 120 Hz, and used an Accmat™ USB wired 19 key number 
numeric keypad as the test input device. The computer was running on a 64 - Bit Windows 7 
Enterprise, Service pack 1, Matlab R2014a and Psychtoolbox version 3.0.11. 
 
Selection of optimal threshold criteria  
An initial study was conducted to determine the optimal threshold criteria for the 4AFTp 
staircase. A randomly selected eye in a convenience sample of 20 healthy adults was tested 
with the flicker test four times on separate occasions during a period of two weeks for each 
criterion run length (T8 and T12). The starting level was set at 15 dL, which is half way between 
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the threshold of about 10 dL for healthy individuals and the maximum available modulation 
level of 20 dL. The overall mean modulation level for the 4 test locations was determined for 
each session and the time taken to perform the test was recorded. Inter-session differences 
were evaluated using Friedman’s test and test–retest coefficients of repeatability were 
calculated for the flicker modulation levels. 
To assess the inherent variability of the test for a typical participant, the inter-participant 
variability was isolated from the intra-participant variability by calculating the mean modulation 
level across participants for each test location and each threshold criterion and then 
normalizing the individual values to this group mean to determine the within-participant 
variability. 
 
Assessment of individual reliability and learning effects 
To assess learning effects over repeats, we evaluated the change in performance of the flicker 
algorithm for 4 volunteers who undertook the test 10 times over a period of 3 months. Learning 
effects were assessed by comparing the test duration and modulation levels of the first session 
with those of the other four sessions.  
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2. Diagnostic performance of the A4FTp flicker test in the detection of glaucoma 
The diagnostic accuracy of the A4FTp flicker test was determined using a case-control design 
in which test results in series of patients with an established diagnosis of COAG were 
compared with those of a control group. Test performance was also compared with two 
commonly used tests for glaucoma case finding: The Frequency Doubling Technology 
Perimeter (FDT); and the iVue Spectral Domain Optical Coherence Tomography (SD-OCT). 
User acceptability of all screening tests was also determined. The study was designed and 
findings reported in accordance with the Standards for Reporting of Diagnostic Accuracy 
criteria.(23) 
 
Study Participants 
Participants eligible for inclusion were consecutive adults (≥40 years) with a clinical diagnosis 
of COAG and were recruited either from the university eye clinic or via a request for volunteers 
in the ‘International Glaucoma Association’ newsletter. The control participants were 
consecutive non-glaucomatous adults (≥40 years), who were recruited from the university eye 
clinic and local optometry practices.  
 
Inclusion and Exclusion Criteria 
There is no universally accepted reference standard for the diagnosis of glaucoma; however, 
optic disc and visual field damage are used to diagnose the presence of glaucoma.(24) The 
diagnosis of COAG was based on a reference standard ophthalmic examination and meeting 
the following diagnostic criteria: open anterior chamber angles; presence of glaucomatous 
optic neuropathy (indexed by localized absence of neuroretinal rim, cup-to-disc ratio 0.7, or 
interocular asymmetry in vertical cup-to-disc ratio 0.2 in similar sized discs and the presence 
of a concordant glaucomatous field defect using the 24-2 Swedish Interactive Thresholding 
Algorithm (SITA) on the Humphrey Visual Field Analyzer (HFA), based on criteria amended 
from Anderson.(25) 
We excluded any participant who had a history of angle closure, significant ocular co-morbidity 
e.g. diabetic retinopathy, retinal vascular occlusions, peripheral retinal abnormalities, optic 
atrophy, visually significant cataract (indexed by the Lens Opacity Classification System III(26) 
(LOCIII) (N≥4.0, C≥2.0, P≥2.0) or a neurological field defect. 
The inclusion criteria for the control participants included: freedom from ocular disease with 
normal appearance of the optic disc, normal fundus, intraocular pressure ≤21 mm Hg and full 
visual fields on the reference examination.   
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Test procedures for each index test 
Figure 2 shows the flow of patients through the study. All participants underwent testing on 
both eyes with all three ‘index tests’, A4FTp flicker test, FDT and iVue OCT, performed in a 
random order by an experienced optometrist who was unaware of the participants’ ocular 
status. This sequence was then followed by a reference standard ophthalmic examination by 
a clinician masked to the index test results. Participants were included in the analysis if they 
had interpretable results in both reference and index tests; those with uninterpretable results 
were excluded. Thresholds of abnormality for the index tests were based on cut-offs commonly 
reported in the literature and were pre-defined before data analysis.  
 
Figure 2. Study flow diagram 
 
 
FDT 
The first generation FDT (Carl Zeiss Meditec Inc,, software version 4.00.0,  
www.zeiss.com/meditec/int/products/ophthalmology-optometry.html) was used in the C20-5 
supra-threshold mode. Contrast thresholds were determined at 17 locations within the central 
20˚ of the visual field. Classification of an abnormal result was based on the following criteria: 
any location missed at the p<5% or any location missed at the p<1% significance level from 
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the manufacturers’ normative database. If any of the indices were unreliable, which included 
false positives, false negative or fixation losses ≥33% or any point missed, the test was 
repeated.  
 
IVue SD-OCT 
IVue SD-OCT (Optovue Inc., software version 3.2.0.42, www.optovue.com/) was used to scan 
the posterior segment of the eye, capturing data from the optic nerve head retinal nerve fibre 
layer (RNFL) and total retinal thickness. Scans were taken through un-dilated pupils under 
dark room conditions. Cut-offs for abnormality were for any RNFL parameter p<1% or p<5% 
from the manufacturers’ normative database.  
 
Reference test 
All participants underwent a reference standard ophthalmic examination on the same day as 
the index tests by an experienced glaucoma-specialist optometrist (with training and 
accreditation within glaucoma clinics in the UK Hospital Eye Service), masked to the index 
tests results. The ocular examination comprised: Log MAR best correct visual acuity; 
refraction; intraocular pressure measurement (IOP) with a Goldmann Applanation Tonometer; 
slit-lamp biomicroscopy including grading of the crystalline lens with the LOCS III and van 
Herick assessment of limbal anterior chamber depth(27) (with potentially occludable angles 
examined using gonioscopy); dilated fundus examination and detailed disc assessment using 
indirect ophthalmoscopy. Visual fields were measured with the Humphrey Field Analyzer 
(HFA) (Carl Zeiss Meditec Inc., www.zeiss.com/meditec/int/products/ophthalmology-
optometry.html) using the Swedish Interactive Thresholding Algorithm 24-2 standard pattern 
(model 720i software version 5.1.2). HFA field-testing was repeated for false positives >15%, 
false negatives or fixation losses >33%. Glaucomatous visual field loss was classified using 
Hodapp Parrish-Anderson criteria.(15)  
 
Evaluation of user acceptability 
Subjects were also asked to complete a questionnaire regarding the acceptability of the 3 
index tests compared to the HFA at the end of reference examination. The questionnaire 
evaluated ease of use, test duration and test comfort using a 7-point Likert scale. 
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Sample Size Calculation 
Sample size was calculated based on the precision around an anticipated sensitivity of 0.85 
with a minimum acceptable precision of ±0.20 with 0.95 probability. This level required a 
sample of 33 participants with glaucoma.(28) 
 
Statistical Analysis for Diagnostic Accuracy Study 
All tests were performed on both eyes for comparison with the clinical assessment of individual 
eyes and the data from one eye was used in the analysis. In the case of participants with 
glaucoma, this was the eye with the greater visual field loss and the right eye for the controls; 
if the right eye in the control group was not eligible, the left eye was selected provided it met 
the inclusion criteria.  
Receiver operator characteristics (ROC) curves were plotted for the ability of the index tests 
to discriminate glaucomatous from non-glaucomatous eyes. Differences in the area under the 
ROC curve (AUROC) for each test parameter at the 95% confidence interval (CI) was 
compared statistically using the DeLong method,(29) a p-value of 0.05 was considered as the 
threshold for significance. Sensitivity, specificity, positive and negative likelihood ratios were 
also calculated. Statistical analysis was performed using SPSS 23.0 software 
(www.ibm.com/SPSS_statistics) and MedCalc 17.4 (www.medcalc.org). 
 
Results 
Development of the Accelerator 4AFC flicker test 
Determination of optimal threshold criteria 
Twenty normal participants (14 males and 6 females) were included in the study, with mean 
age 33.8 years (SD± 8.5) and mean spherical refractive error -0.50 D ±2.41 (2). The analysis 
was based on 10 right eyes and 10 left eyes. Table 1 shows the mean inter-session modulation 
levels for all 4 locations and run durations for each threshold criterion (T8 vs T12). The 
intersession differences in modulation levels were not statistically significant for either the T8 
or the T12 termination criterion. In terms of run duration, inter-session differences for the 
shorter T8 termination criterion were similar; however, there was a significant decrease in test 
duration for T12. Overall, the mean durations were nearly twice as long for the T12 than the 
T8 criterion.  
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Table 1: Inter-session modulation levels and test durations (means and 95% CI per eye) 
 Session 1 Session 2 Session 3 Session 4 p-value 
% modulation (T8)  9.22 ± 0.17 9.57 ± 0.27 9.17 ± 0.15 9.07 ± 0.18 0.11 
% modulation (T12)  8.61 ± 0.43 8.69 ± 0.41 8.76 ± 0.40 8.90 ± 0.37 0.11 
Duration (T8) (s)  81 ± 22 71 ± 9 76 ± 15 73 ±13 0.36 
Duration (T12) (s)  166 ± 49 148 ± 40 148 ± 40 126 ± 31 < 0.001 
 
The total number of responses in the T8 condition averaged 42, implying that the stable 
threshold values were obtained in just over 10 responses per visual field location. The 
corresponding number for the T12 condition averaged 76, or 19 responses per visual field 
location.  
The differences in % modulation among the four chosen field locations with either the T8 or 
T12 criterion were not statistically significant (Figure 3). The average within-participant 
standard deviation (SD) across the four locations was 0.52 dL and 1.32 dL for T8 and T12 
respectively. The corresponding values for the Coefficient of Repeatability are 1.44 dL and 
3.65 dL.  
 
 
Figure 3. Decilog modulation levels over the four visual field locations, normalized to the group 
mean, for each threshold criterion. These error bars thus represent the average individual 
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variability at the four visual field locations. (UN – Upper Nasal, LN – Lower Nasal, UT- Upper 
Temporal and LT – Lower Temporal) 
  
Assessment of threshold stability and learning effects 
To study threshold stability, we evaluated the test-retest repeatability of the flicker algorithm 
by repeating the test 10 times over a 4-month period in four control observers to determine 
stability of the estimates. The average threshold values for the T8 and T12 are plotted in Figure 
4A and B. For the T8 condition, all four slopes are less than 0.5 dL over the 10 runs, with small 
differences in the average sensitivity across observers and an average  standard deviation 
(SD) of 1.66 dL. For the T12 condition, the data are generally more variable, with an average 
SD of 1.75 dL and somewhat lower threshold values, but there are again no significant trends 
for either improvement with practice.   
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Figure 4.  Trend analysis over 10 runs of the thresholds for each field location averaged for 
four control observers. A:  Data for the criterion run length of 8 (T8 condition). B: Data for the 
criterion run length of 12 (T12 condition). None of the slopes differed significantly from zero 
(p<0.05). 
 
Diagnostic performance of the A4FTp flicker test in the detection of glaucoma 
Participant characteristics  
Eighty-one participants were assessed for initial eligibility and invited to participate. Three 
participants were excluded from the analysis: 2 control participants (one had uninterpretable 
test results on all visual function tests and another had suspected glaucoma) and 1 glaucoma 
participant (who had a bilateral neurological visual field defect). In total, 38 controls and 40 
participants diagnosed with glaucoma were included in the final analysis. The glaucoma group 
contained more pseudophakic test eyes (n=22, 55%) compared to the controls (n=2, 5.3%). 
There was no statistically significant difference between the two groups in visual acuity, 
refractive error or gender. Most participants were of Caucasian origin and the average ages 
for the control and glaucoma groups were 61.6 years (95% CI 58.1-65.0) and 71.9 years (68.8-
74.9) respectively.  
Glaucoma cases were further categorised according to glaucoma severity using the criteria 
from Hodapp et al(15) as: early (n=13, 32.5%), moderate (n=14, 35%) and advanced glaucoma 
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(n=13, 32.5%). A summary of the demographic and clinical data for the controls and glaucoma 
participants is provided in Table 2; t-tests were used to compare the differences between the 
two groups, apart from gender, where a chi-squared test was used.  
 
Table 2. Demographical and summary clinical data for all participants and each group.  
 Overall Control Glaucoma P 
No. Participants 78 38 40  
Age Years (Mean ± SD) (years) 66.8±11.2 61.6±10.6 71.9±9.4 <0.001 
Female No. (%) 46 (59%) 22 (57.9%) 24 (60%) 0.85 
Ethnicity 
Caucasian No. (%) 
65 (83.3%) 28 (73.7%) 37 (92.5%) 
 Asian Indian No. (%) 12 (15.4%) 10 (26.3%) 2 (5%) 
African Origin No. (%) 1 (1.3%) 0 (0%) 1 (2.5%) 
Visual Acuity (Log) (Mean ± SD) 0.07±0.15 0.04±0.17 0.09±0.12 0.092 
IOP (mm Hg) (Mean ±SD) 16.4±4.42 17.5±2.5 15.3±5.5 0.024 
Refractive Error (DS) (Mean ± SD) -0.50±3.20 -0.26±3.59 -0.72±2.81 0.53 
Refractive Error (DC) (Mean ± SD) -0.87±0.84 -0.72±0.71 -1.01±0.93 0.13 
Humphrey SAP SITA 24-2 
Threshold MD (Mean ± SD) (dB) 
-5.75±7.41 
 
-0.71±1.55 
 
-10.53±7.61 
 
<0.001 
DS: Dioptric Sphere; DC: Dioptric Cylinder; MD: Mean Deviation; PSD: Pattern Standard Deviation; 
SAP; Standard automated perimetry. 
 
Diagnostic performance of the A4FTp 
The best performing parameter for the A4FTp (as determined by the greatest AUROC) was 
the mean threshold from all four tested locations. The A4FTp achieved a sensitivity and 
specificity of 83% and 74% respectively, with an AUROC of 0.82 (95% CI 0.73-0.92). Figure 
5 shows a histogram of the mean log flicker thresholds for the control and glaucoma 
subgroups with their 95% confidence intervals. Mean log threshold increased with increasing 
disease severity, although there was overlap in the distribution for control participants and 
those with early glaucoma. Consequently, whilst the A4FTp test identified 93% and 100% of 
moderate and severe glaucoma respectively, it identified half of those diagnosed with early 
glaucoma. Although the sensitivity of the test could potentially be increased by lowering the 
log threshold, this would lead to an unacceptable reduction in specificity (see Figure 6, which 
shows a sensitivity/specificity plot for different thresholds for the A4FTp).  
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Figure 5. Histogram of the mean log thresholds of control and glaucoma subgroups.  
. 
Figure 6. Sensitivity and specificity plot for A4FTp 
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Comparison of the A4FTp with other index tests 
Table 3 displays the diagnostic performance of all the index tests, the optimal threshold for 
the FDT was: any location missed at p<5% level, and for the SD-OCT: any quadrant at the 
p<1% level in the RNFL. The AUROC for the FDT and SD-OCT, respectively were 0.91 (0.82-
0.96) and 0.90 (0.83-0.967); sensitivities and specificities were (90%, 92%) and (88%, 84%), 
respectively.  
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Table 3. Diagnostic performance of the index tests. 
 Index Test 
Parameter 
Best 
Cut-
off 
Value 
(dL) 
Sensitivity 
(%) 
Specificity 
(%) 
PLR NLR AUC at 95% 
Confidence Interval 
A4FTp 
Mean of 4 
Locations 
>12.3 82.5 73.7 3.1 0.2 0.82 (0.73-0.92) 
Superior 
hemifield 
>10.8 95.0 55.3 2.1 0.1 0.79 (0.69-0.88) 
Inferior 
hemifield 
>13.1 75.0 73.7 2.9 0.3 0.78 (0.67-0.87) 
Nasal 
hemifield 
>13.3 82.5 73.7 3.1 0.2 0.80 (0.70-0.88) 
Temporal 
hemifield 
>10.5 95.0 57.9 2.3 0.1 0.79 (0.68-0.87) 
Superior 
nasal 
quadrant 
>10.4 92.5 50.0 1.9 0.2 0.77 (0.66-0.86) 
Superior 
temporal 
quadrant 
>10.9 77.5 68.4 2.5 0.3 0.76 (0.65-0.85) 
Inferior 
nasal 
quadrant 
>14.1 67.5 73.7 2.6 0.4 0.74 (0.63-0.84) 
Inferior 
temporal 
quadrant 
>10.3 97.5 47.4 1.9 0.1 0.75 (0.64-0.84) 
FDT   
Any point 
missed at 
p<5% level 
>0 90.0 92.1 11.4 0.1 
 
0.91 (0.82- 0.96) 
 
Any point 
missed at 
p<1% level 
>0 82.5 97.4 31.7 0.2 0.90 (0.81-0.96) 
iVue 
SD-
OCT 
RNFL 
Any 
quadrant at 
p<1% 
- 87.5 84.2 5.5 0.1 0.90 (0.83-0.97) 
Any 
quadrant at 
p<5% 
- 95 68.4 3.0 0.1 0.82 (0.74-0.90) 
 
PLR: Positive Likelihood ratio; NLR: Negative Likelihood Ratio. 
 
Table 4 shows pairwise comparisons of the AUROC curves between the index tests. There 
was no statistical significances between the A4FTp and FDT p<1% level (p=0.15) or FDT 
p<5% level (p=0.12). Comparison with respect to the A4FTp and the SD-OCT parameters; 
SD-OCT RNFL any quadrant at the p<1% level (p=0.18) and p<5% level (p=0.91) also showed 
no statistically significant differences.   
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Table 4. Pairwise comparison of ROC curves of the index tests.  
Test comparisons 
Difference 
between the 
areas 
95% 
Confidence 
Interval 
P 
A4FTp vs FDT p<1% any 
point missed 
0.08 -0.03-0.18 0.15 
A4FTp vs FDT p<5% any 
point missed 
0.09 -0.02-0.02 0.12 
A4FTp vs SD-OCT p<1% 0.07 -0.04-0.18 0.18 
A4FTp vs SD-OCT p<5% 0.01 -0.11-0.12 0.91 
 
Figure 7 shows a Venn diagram for the best performing criteria of each index test in identifying 
the glaucoma participants. The A4FTp detected slightly fewer glaucoma cases (n=33, 83%) 
than the FDT (n=36, 90%) or SD-OCT (n=35, 88%). Two cases (5%) were missed by all three 
index tests. The diagram shows that a screening strategy that combines a structural test (SD-
OCT) with a functional test (FDT or A4FTp) increases the likelihood of detecting the disease.  
 
 
Figure 7. Venn diagram of best performing parameter from the index tests in identifying the 
glaucoma cases alone or combined with the other tests. The numbers within the circles 
represent the number of participants identified by each test. In two participants all tests were 
normal.  
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Test duration 
Table 5 and Figure 8 depicts shows the time taken to perform the functional tests (including 
the HFA 24-2, which was undertaken as part of the reference examination). The mean time 
taken for all participants in the tests were FDT C20-5 (61.6±34.8 seconds), A4FTp (141.8±85.6 
seconds) and HFA (364.0±79.3 seconds), which were significantly different between all three 
tests (p<0.001). There were also statistically significant differences between the control and 
glaucoma groups for the HFA (p<0.001), FDT C20-5 (p<0.001) and A4FTp (p<0.008). 
 
Table 5. Time taken to perform each functional test. 
 Total Control Glaucoma P 
HFVA SITA 24-2 
Threshold time 
taken (sec) Mean 
± SD) 
364.0±79.3 
 
306.5±29.4 
 
 
418.6±73.0 
 
 
<0.001 
FDT time (Supra-
threshold C20-5) 
time taken (sec) 
Mean ± SD 
61.6±34.8 
 
36.5±8.9 
 
 
85.5±33.4 
 
<0.001 
A4Tp Threshold 
time taken (sec) 
Mean ± SD) 
141.8±85.6 
 
115.7±44.5 
 
 
166.5±106.3 
 
0.008 
 
 
Figure 8. Box and Whiskers plot of time taken to perform each functional test. 
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User acceptability 
Figure 9 shows the Likert scores responses from the tests from an acceptability survey; there 
was a higher proportion of participants who found the HFA uncomfortable, too long and difficult 
to perform, compared to the other index tests. The A4FTp, FDT and SD-OCT had a similar 
proportion of participants (>90%) rating the tests as not uncomfortable or not too long. 
However, more participants found the A4FTp difficult to perform in its current configuration. 
There were no adverse events occurring when performing any of the index tests.  
 
Figure 9. Likert responses from user acceptability survey from all participants. 
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Discussion 
Glaucoma is the leading cause of irreversible blindness worldwide. A recent systematic review 
estimated that glaucoma was responsible for 6.6% of total global blindness and 2.2% of all 
moderate and severe visual impairment.(30) The lack of symptoms in its early stages, coupled 
with inequitable access to healthcare in many countries, contributes to high rates of 
undiagnosed glaucoma and late clinical presentation. The main aim of the study was therefore 
to evaluate the diagnostic performance of a simple screening test that could be potentially 
used in conjunction with other clinical tests to detect glaucoma in a home setting or in 
underserved populations.  
 
The A4FTp measures flicker thresholds at four fixed locations strategically placed to detect 
the arcuate or nasal step defects that are commonly seen in glaucoma. The flicker rate was 
set at 30Hz, the value found to be diagnostic of glaucoma in previous studies.(7, 31) Flicker 
sensitivity has been shown to be resilient to optical blur(11) and the large stimulus size 
minimised the impact of fixation losses. Furthermore, presenting the stimuli in a red field 
reduces optical scatter due to opacities in the ocular media, including cataract.  
 
Psychophysical tests that are used for clinical purposes should have a minimum set of 
psychophysical attributes before they can be introduced for clinical testing, including an 
acceptable within and between test variation. Within-test variability is caused by several 
aspects: neural noise, decision criteria, and thresholding strategy.(32, 33) Between-test variability 
has been attributed to ocular and neural sensitivity fluctuations.(34) The variability that occurs 
during test and retest is quantified by the degree of scatter between measurements taken at 
different test sessions.(34-36) Considering first the stability over time, we found that there was 
no significant drift in the estimated values for either threshold criterion (T8 or T12) in normals 
for either the short- or long-term test series (although the duration for T12 did significantly 
decrease over time). Thus, the A4FTp staircase was equally stable under all test conditions. 
However, there was a notable difference between the criteria in the variation across 
individuals, which had the remarkably low standard deviation of 0.52 dL for T8 compared with 
1.32 dL for T12. These values may be compared with the standard deviation values of 
approximately 1.7 dL reported for the population variation of 2AFC flicker threshold estimates 
in a previous study.(37) Thus, while the standard deviation for the 12-point staircase criterion is 
close to the previously reported range, the 8-point criterion markedly reduces the standard 
deviation to about one third of this level, implying that the physiological strain of the longer 
runs overcame the statistical advantage of the increased number of samples. Since variance 
is defined as the square of the standard deviation, this result further implies that about 90% of 
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the variance in the previous methods, and in the 12-point criterion staircase, was due to 
methodological variations, with no more than 10% of the variance attributable to inherent 
population variability. Moreover, there is no significant gain in reliability for the extra time spent 
to reach the 12-point criterion, and, though slightly lower on average, the threshold values 
themselves are not significantly different from those for the 8-point criterion.  Thus, we have 
to conclude from the 20-normal participant results that, of the two approaches evaluated, the 
8-point criterion staircase is a strikingly effective approach to flicker threshold measurement, 
with no evident disadvantages and a clear time advantage over the 12-point criterion staircase. 
 
The most important characteristic of a screening test is its ability to differentiate between 
normal and diseased individuals. To assess the diagnostic accuracy of the A4FTp, we 
measured flicker thresholds in 40 subjects with COAG and 38 normal controls. Based on a 
comparison of areas under the ROC curve, the overall performance of the A4FTp was similar 
to the FDT (C20-5 algorithm) and the SD-OCT (RNFL thickness outside normal limits). The 
best performing criterion for the A4FTp was the mean threshold of all 4 stimulus locations. 
Using this criterion, the test identified 33 out of the 40 glaucoma cases in our sample (83%). 
All cases of advanced glaucoma were detected, all but one of the moderate glaucoma’s and  
half of the early glaucoma’s. The mean time taken for all participants to perform the A4FTp 
was within the clinically recognised ‘3-minute period of vigilance’; this is advantageous in terms 
of response variability, as beyond this time it has been noted that the response variability 
increases.(38) User acceptability of the A4FTp was positive, with similar acceptability 
questionnaire scores to the FDT and SD-OCT, in terms of comfort and participant’s opinion 
on the duration of the test.  
 
The ‘optimal’ threshold criterion for the A4FTp was based on an equal weighting for sensitivity 
and specificity. Sensitivity and specificity are inversely proportional and therefore lowering the 
threshold to maximise sensitivity leads to a corresponding reduction in specificity. A further 
issue with population screening for glaucoma is the relatively low prevalence of the disease. 
Based on a glaucoma prevalence of 5% in high-risk populations(30) and a test with 90% 
sensitivity and 90% specificity, only one in three persons screening positive will have the 
disease. Currently, no single test for glaucoma has been shown to have a sufficiently high 
sensitivity and specificity for the detection of glaucoma in the general population.(39) It is 
therefore likely that future screening strategies for glaucoma will employ combinations of tests 
and will target those most likely to be affected by vision loss in their lifetime,(40) putting a 
premium on the rapidity of the tests selected for inclusion. Combining structural and functional 
testing can be used to improve the sensitivity or specificity for glaucoma detection, depending 
on whether the priority is to maximise true positives or minimise false positives.(41) For 
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example, if structural and functional screening tests are used and disease positives are 
defined as those who test positive by either test, there will be a net increase in sensitivity; 
conversely, a strategy where disease negatives are defined as those who test negative on 
both tests will maximise specificity.  
 
This study has a number of strengths: the design, analysis and reporting of the diagnostic 
accuracy study complied with the principles of the Standards for Reporting of Diagnostic 
Accuracy (STARD). The performance of the index tests was compared in a representative 
sample of participants with the target condition, with a range of disease severities. The 
reference standard and index tests were conducted on the same day as the index tests by an 
experienced clinician masked to the index test results. The reference standard for COAG was 
based on a comprehensive ophthalmic examination typical of that conducted in a hospital 
glaucoma unit. However, since both structural and functional tests were evaluated for the case 
definition, this required both established visual field loss and glaucomatous disc damage to 
be present.  Although the use of a case-control design may have artificially overestimated the 
performance of the A4FTp, given the comparative nature of the study, the same degree of 
bias would apply to all tests. Similarly, although the age of the control and glaucoma groups 
differed by approximately a decade, the relative effect of an age-related loss of flicker 
sensitivity would have applied equally to the performance of the FDT. 
 
Whilst the relative performance of the three index tests was similar based on AUROC analysis, 
the specificity for the A4FTp was the lowest of all three tests. Three participants in the control 
group had log threshold values for the A4FTp well outside the 95% confidence interval. If these 
‘outliers’ were removed from the A4FTp, the overall specificity would increase from 74% to 
80%. With further refinement and optimisation, the data suggest that the A4FTp could have a 
role in combination with other tests for glaucoma screening. The test has a number of 
advantages including: its easy administration, ready interpretation, relatively short testing time 
and robustness to the effects of media opacity or refractive error. Following the success of this 
proof of concept study, we are currently in the process of optimising the A4Ftp for a touch 
screen tablet display to increase its portability.  
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